Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 7/20 | 0.52 |
| ▸ | MGAM | O43451 | 6/20 | 0.52 |
| ▸ | AMY1A | P0DUB6 | 6/20 | 0.52 |
| ▸ | SI | P14410 | 6/20 | 0.52 |
| ▸ | MGAM2 | Q2M2H8 | 6/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | F2 | P00734 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.48 |
| ▸ | MITF | O75030 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12116963 | 0.92 | KMT2A (0.53) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL12117031 | 0.91 | KMT2A (0.56) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL11357460 | 0.87 | KCNMA1 (0.54) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL11357912 | 0.84 | MGAM (0.59) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL12117032 | 0.83 | ALDH1A1 (0.54) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL11353826 | 0.83 | MGAM (0.57) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL12116959 | 0.82 | GAA (0.53) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL12116960 | 0.82 | ASAH1 (0.50) | KMT2AALDH1A1HTTMAPTTSHR | |
| SCHEMBL425552 | 0.81 | KMT2A (0.59) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL11357689 | 0.78 | MEN1 (0.43) | GAAMGAMAMY1ASIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9353082-B2 | Pharmaceutical compounds | BIAL—PORTELA & CA, S.A. (PT) | 2016-05-31 | — | — | US | disclosed |
| US-20120065191-A1 | PHARMACEUTICAL COMPOUNDS | BIAL - PORTELA & Cª, S.A. (PT) | 2012-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120065191-A1 | PHARMACEUTICAL COMPOUNDS | FAAH, FAAH2, ASAH1 | GAA 184/4885MGAM 1034/4885AMY1A 955/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.